Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products... Show more
LNTH saw its Momentum Indicator move below the 0 level on September 04, 2025. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 77 similar instances where the indicator turned negative. In of the 77 cases, the stock moved further down in the following days. The odds of a decline are at .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where LNTH declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Aroon Indicator for LNTH entered a downward trend on August 15, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where LNTH's RSI Oscillator exited the oversold zone, of 24 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
The Moving Average Convergence Divergence (MACD) for LNTH just turned positive on August 21, 2025. Looking at past instances where LNTH's MACD turned positive, the stock continued to rise in of 48 cases over the following month. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where LNTH advanced for three days, in of 344 cases, the price rose further within the following month. The odds of a continued upward trend are .
LNTH may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.191) is normal, around the industry mean (16.653). P/E Ratio (14.561) is within average values for comparable stocks, (74.307). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.902). LNTH has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.031). P/S Ratio (2.589) is also within normal values, averaging (42.886).
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock slightly better than average.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. LNTH’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
a manufacturer of medical imaging products
Industry PharmaceuticalsGeneric
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
IEYCX | 8.84 | 0.06 | +0.68% |
Macquarie Climate Solutions C | |||
GSIYX | 22.57 | 0.04 | +0.18% |
Goldman Sachs GQG Ptnrs Intl Opps R6 | |||
LBFIX | 60.12 | -0.06 | -0.10% |
ClearBridge Select I | |||
PAGLX | 46.43 | -0.07 | -0.15% |
T. Rowe Price Global Growth Stock Adv | |||
LMUSX | 26.71 | -0.07 | -0.26% |
Franklin U.S. Large Cap Equity FI |
A.I.dvisor tells us that LNTH and EOLS have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that LNTH and EOLS's prices will move in lockstep.
Ticker / NAME | Correlation To LNTH | 1D Price Change % | ||
---|---|---|---|---|
LNTH | 100% | +1.73% | ||
EOLS - LNTH | 32% Poorly correlated | +2.00% | ||
CRDL - LNTH | 29% Poorly correlated | -1.80% | ||
MKKGY - LNTH | 27% Poorly correlated | +1.66% | ||
ZTS - LNTH | 22% Poorly correlated | +0.08% | ||
ACB - LNTH | 22% Poorly correlated | +1.66% | ||
More |
Ticker / NAME | Correlation To LNTH | 1D Price Change % |
---|---|---|
LNTH | 100% | +1.73% |
Pharmaceuticals: Generic industry (223 stocks) | 14% Poorly correlated | +2.48% |